133 related articles for article (PubMed ID: 38850717)
21. Discovery of Orally Bioavailable Phthalazinone Analogues as an ENPP1 Inhibitor for STING-Mediated Cancer Immunotherapy.
Cho Y; Kang M; Ji SH; Jeong HJ; Jung JE; Oh DH; Park S; Park YY; Choi J; Kim S; Kim NJ; Lee DH; Park CS; Han SJ; Lee S; Choi J
J Med Chem; 2023 Nov; 66(22):15141-15170. PubMed ID: 37963811
[TBL] [Abstract][Full Text] [Related]
22. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
[TBL] [Abstract][Full Text] [Related]
23. Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration.
Niu J; Bai H; Li Z; Gao Y; Zhang Y; Wang X; Yang Y; Xu Y; Geng M; Xie Z; Zhou B
Eur J Med Chem; 2022 Aug; 238():114482. PubMed ID: 35671593
[TBL] [Abstract][Full Text] [Related]
24. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
[TBL] [Abstract][Full Text] [Related]
25. Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy.
Yu Y; Bogdan M; Noman MZ; Parpal S; Bartolini E; Van Moer K; Kleinendorst SC; Bilgrav Saether K; Trésaugues L; Silvander C; Lindström J; Simeon J; Timson MJ; Al-Hashimi H; Smith BD; Flynn DL; Alexeyenko A; Viklund J; Andersson M; Martinsson J; Pokrovskaja Tamm K; De Milito A; Janji B
Mol Oncol; 2024 Mar; ():. PubMed ID: 38506049
[TBL] [Abstract][Full Text] [Related]
26. Sono-Driven STING Activation using Semiconducting Polymeric Nanoagonists for Precision Sono-Immunotherapy of Head and Neck Squamous Cell Carcinoma.
Jiang J; Zhang M; Lyu T; Chen L; Wu M; Li R; Li H; Wang X; Jiang X; Zhen X
Adv Mater; 2023 Jul; 35(30):e2300854. PubMed ID: 37119091
[TBL] [Abstract][Full Text] [Related]
27. Cancer Radiosensitization Nanoagent to Activate cGAS-STING Pathway for Molecular Imaging Guided Synergistic Radio/Chemo/Immunotherapy.
Wu Z; Li Q; Zhu K; Zheng S; Hu H; Hou M; Qi L; Chen S; Xu Y; Zhao B; Yan C
Adv Healthc Mater; 2024 Jun; 13(14):e2303626. PubMed ID: 38387885
[TBL] [Abstract][Full Text] [Related]
28. Co-delivery of Phagocytosis Checkpoint Silencer and Stimulator of Interferon Genes Agonist for Synergetic Cancer Immunotherapy.
Lu ZD; Chen YF; Shen S; Xu CF; Wang J
ACS Appl Mater Interfaces; 2021 Jun; 13(25):29424-29438. PubMed ID: 34129318
[TBL] [Abstract][Full Text] [Related]
29. Mn-phenolic networks as synergistic carrier for STING agonists in tumor immunotherapy.
Meng Y; Huang J; Ding J; Zhou H; Li Y; Zhou W
Mater Today Bio; 2024 Jun; 26():101018. PubMed ID: 38516172
[TBL] [Abstract][Full Text] [Related]
30. Local immunotherapy of glioblastoma: A comprehensive review of the concept.
Sabahi M; Salehipour A; Bazl MSY; Rezaei N; Mansouri A; Borghei-Razavi H
J Neuroimmunol; 2023 Aug; 381():578146. PubMed ID: 37451079
[TBL] [Abstract][Full Text] [Related]
31. Cocktail strategy based on a dual function nanoparticle and immune activator for effective tumor suppressive.
Li Q; Chen Q; Yang X; Zhang Y; Lv L; Zhang Z; Zeng S; Lv J; Liu S; Fu B
J Nanobiotechnology; 2022 Feb; 20(1):84. PubMed ID: 35177088
[TBL] [Abstract][Full Text] [Related]
32. Sonodynamic amplification of cGAS-STING activation by cobalt-based nanoagonist against bone and metastatic tumor.
Lei J; Zhang W; Ma L; He Y; Liang H; Zhang X; Li G; Feng X; Tan L; Yang C
Biomaterials; 2023 Nov; 302():122295. PubMed ID: 37666101
[TBL] [Abstract][Full Text] [Related]
33. Combination of STING agonist with anti-vascular RGD-(KLAKLAK)
Czapla J; Drzyzga A; Ciepła J; Matuszczak S; Jarosz-Biej M; Pilny E; Cichoń T; Smolarczyk R
Cancer Immunol Immunother; 2024 Jun; 73(8):148. PubMed ID: 38832958
[TBL] [Abstract][Full Text] [Related]
34. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS).
Messaoud-Nacer Y; Culerier E; Rose S; Maillet I; Rouxel N; Briault S; Ryffel B; Quesniaux VFJ; Togbe D
Cell Death Dis; 2022 Mar; 13(3):269. PubMed ID: 35338116
[TBL] [Abstract][Full Text] [Related]
35. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
[TBL] [Abstract][Full Text] [Related]
36. Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies.
Huang M; Cha Z; Liu R; Lin M; Gafoor NA; Kong T; Ge F; Chen W
Front Immunol; 2024; 15():1399926. PubMed ID: 38817608
[TBL] [Abstract][Full Text] [Related]
37. Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy.
Lu X; Miao L; Gao W; Chen Z; McHugh KJ; Sun Y; Tochka Z; Tomasic S; Sadtler K; Hyacinthe A; Huang Y; Graf T; Hu Q; Sarmadi M; Langer R; Anderson DG; Jaklenec A
Sci Transl Med; 2020 Aug; 12(556):. PubMed ID: 32801144
[TBL] [Abstract][Full Text] [Related]
38. STING Agonists as Cancer Therapeutics.
Amouzegar A; Chelvanambi M; Filderman JN; Storkus WJ; Luke JJ
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070756
[TBL] [Abstract][Full Text] [Related]
39. Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors.
Yi M; Niu M; Wu Y; Ge H; Jiao D; Zhu S; Zhang J; Yan Y; Zhou P; Chu Q; Wu K
J Hematol Oncol; 2022 Oct; 15(1):142. PubMed ID: 36209176
[TBL] [Abstract][Full Text] [Related]
40. Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity.
Kim JC; Liu X; Fitzgerald K; Eng JS; Orf J; O'Brien SA; Belmontes B; Casbon AJ; Novitskiy SV; Tarbell KV; DeVoss J; Egen JG
Cancer Immunol Immunother; 2023 May; 72(5):1327-1335. PubMed ID: 36394642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
